» Drug, Devices, and Supplements

» Physician Accountability

» Consumer Product Safety

» Worker Safety

» Health Care Delivery

» Auto and Truck Safety

» Global Access to Medicines

» Infant Formula Marketing


Product Recalls

April 17-May 14, 2014

Health Letter, June 2014

Class I

Adipotrim XT dietary supplement, 30 capsules/bottle.

JaDera weight loss supplement, capsules, 30-count bottle.

Lidiy dietary supplement capsules.

PHUK Sexual Enhancement Ultimate Pleasure, 400 mg capsules.

Prolifta dietary supplement, 400 mg capsules.

RezzRX capsules, single blister pack and 20-count bottle.

Slim Expert dietary supplement, softgel 650 mg capsules.

Slim Fortune dietary supplement capsules.

Virilis Pro, 450 mg capsules.

Xiyouji Qingzhi capsulres, 300mg, 20-count box.

Class II

Blu Pharmaceuticals Inc. is recalling metformin hydrochloride tablets, 500 and 1000 mg. For more information:

Caraco Pharmaceutical Laboratories is recalling venlafaxine hydrochloride extended-release tablets, 37.5 and 150 mg. For more information:

Fluoxetine capsules, 20 mg, 30-count bottles.

Glyburide and metformin hydrochloride tablets, 5mg/500mg, 500-count bottle.

Methyldopa tablets, 500 mg, 100-count bottle.

Metoprolol succinate extended-release tablets, 50 mg, 30-count bottle.

Ohm Laboratories Inc. is recalling numerous cold and allergy products marketed under pharmacy names. For more information:

Teva Pharmaceuticals is recalling fluoxetine capsules, 10 and 20 mg, in 100- and 500-count bottles. For more information:

Teva Pharmaceuticals is recalling indomethacin capsules, 25 and 50 mg. For more information:


For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at

Copyright © 2016 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.


To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.